Ken Griffin acquired 578 Thousand AbCellera Biologics shares worth $2.24 Million. That's 0.00% of their equity portfolio (2123rd largest holding). The first AbCellera Biologics trade was made in Q1 2021. Since then Ken Griffin bought shares six more times and sold shares on five occasions. The investor's estimated purchase price is $7.79 Million, resulting in a loss of 71%.